Article

Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking.

Center of Relevance and Excellence in NDDS, Pharmacy Department, The M. S. University of Baroda, G H Patel building, Donor's Plaza, Fatehgunj, Vadodara, Gujarat, India.
AAPS PharmSciTech (Impact Factor: 1.78). 06/2008; 9(2):377-89. DOI: 10.1208/s12249-008-9052-x
Source: PubMed

ABSTRACT The objective of the present investigation was to reduce the bitterness with improved dissolution, in acidic medium (pH 1.2), of mefloquine hydrochloride (MFL). Microparticles were prepared by coacervation method using Eudragit E (EE) as polymer and sodium hydroxide as precipitant. A 3(2) full factorial design was used for optimization wherein the drug concentration (A) and polymer concentration (B) were selected as independent variables and the bitterness score, particle size and dissolution at various pH were selected as the dependent variables. The desirability function approach has been employed in order to find the best compromise between the different experimental responses. The model is further cross validated for bias. The optimized microparticles were characterized by FT-IR, DSC, XRPD and SEM. Bitterness score was evaluated by human gustatory sensation test. Multiple linear regression analysis revealed that the reduced bitterness of MFL can be obtained by controlling the dissolution of microparticles at pH 6.8 and increasing the EE concentration. The increase in polymer concentration leads to reduction in dissolution of microparticles at pH > 5 due to its insolubility. However the dissolution studies at pH 1.2 demonstrated enhanced dissolution of MFL from microparticles might be due to the high porosity of the microparticles, hydrophilic nature of the EE, and improved wettability, provided by the dissolved EE. The bitterness score of microparticles was decreased to zero compared to 3+ of pure ARM. In conclusion the bitterness of MFL was reduced with improved dissolution at acidic pH.

0 Bookmarks
 · 
154 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this research was to mask the bitter taste of Rizatriptan benzoate (RB) and to formulate an oral disintegrating tablet (ODT) of the taste-masked drug. Taste masking was done by mass extrusion with aminoalkylmethacrylate copolymer, Eudragit EPO, in different ratios. The drug: polymer ratio was optimized based on bitterness score and RB -polymer interaction. Taste masking was evaluated by checking the in vitro release of RB in simulated salivary fluid (SSF) of pH 6.8 and by sensory evaluation in human volunteers. Fourier Transform Infrared Spectroscopy (FTIR) and Differential Scanning Calorimetry (DSC) were performed to identify the physicochemical interaction between RB and the polymer. For formulation of rapid-disintegrating tablets of RB, the batch that depicted optimum release of RB in SSF, was considered. ODTs of Rizatriptan Benzoate were prepared by using superdisintegrants namely, sodium starch glycolate, crospovidone and croscarmellose sodium using the direct compression method. The tablets were evaluated for hardness, friability, wetting time, in vitro disintegration time. The optimum formulation was selected and the tablets were evaluated for thickness, drug content, content uniformity and mouth feel, in vivo disintegration time, in vitro drug release at pH 1.2 and 6.8 and stability study. Eudragit EPO was able to mask the bitter taste of Rizatriptan benzoate effectively in 1:1 ratio by mass extrusion method. FTIR and DSC data revealed absence of RB-polymer interaction. ODTs containing crospovidone (5% w/w) depicted minimum disintegration time. Taste evaluation of ODT in human volunteers revealed considerable taste masking, with all 6 volunteers, reporting the taste of ODTs as good in comparison with RB. Thus, results conclusively demonstrated successful taste masking and rapid disintegration of the formulated tablets in the oral cavity with adequate dissolution. The research work suggests a rapid, simple and cost effective mass extrusion method for formulation of ODT of Rizatriptan benzoate. INTRODUCTION migraine attack and serotonin agonists relieve attacks [1].
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract This study was intended to design an orally disintegrating tablet (ODT) formulation that can mask the extremely bitter and metallic taste of phencynonate HCl by novel ion-exchange resins. The drug-resin complexes (DRCs) were prepared and characterized by scanning electron microscopy, X-ray powder diffraction and differential scanning calorimetry. In vitro properties (dissolution, wetting time and disintegration time) and in vivo behavior (disintegration time and taste-masking effect) in healthy volunteers of the prepared ODTs were also investigated. The drug was changed from the crystal structure to the amorphous form in the DRC. Compared with commercial tablets, the in vitro and in vivo disintegration of optimized DRC-loaded ODTs with a drug-resin ratio of 1:1 was greatly improved and better palatability with a low bitterness index (0.33) was obtained. The current DRC-loaded ODT could promise a good way to mask the unpleasant taste of certain drugs and accordingly improve the patient compliance.
    Drug Development and Industrial Pharmacy 05/2014; · 2.01 Impact Factor
  • Current Nanoscience 04/2013; 9(2):293-302. · 1.42 Impact Factor

Full-text (2 Sources)

Download
14 Downloads
Available from
May 23, 2014